Supernus Pharmaceuticals Inc XNAS: SUPN

Supernus Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Supernus Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Supernus Pharmaceuticals Inc
Rating: 3.032833375
Author: Trendlyne DVM scores

Strong Performer, Under Radar

Download real time

32.28 0.12 (0.37%)

26.44% Gain from 52W Low

403.0K XNAS Volume

XNAS 18 Mar, 2025 5:30 PM (EDT)

High Financial Strength

66.7 / 100

Affordable Valuation

59.3 / 100

Technically Neutral

50.0 / 100

Strong Performer, Under Radar These stocks are with good quality scores and with strong financials. They are affordably priced stocks and can give good returns View Similar Embed DVM

39

1Yr Price target upside is 20%

5 analysts

Supernus Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Supernus Pharmaceuticals Inc FAQ

How is Supernus Pharmaceuticals Inc today?

Supernus Pharmaceuticals Inc today is trading in the green, and is up by 0.37% at 32.28.

How has Supernus Pharmaceuticals Inc performed historically?

Supernus Pharmaceuticals Inc is currently trading up 0.37% on an intraday basis. In the past week the stock rose 0.81%. stock has been down -8.97% in the past quarter and fell -5.59% in the past year. You can view this in the overview section.